baber/WOPTO huggingface dataset:
Patent AU-2002341852-A1 (AU)
Title: Low gloss asa resin
Inventor: CHANG MOH-CHING OLIVER
IPC: C08G59/50
Filed: 2002-09-23
Abstract: A thermoplastic molding composition comprising a grafted acrylate rubber (ASA) and a gloss reducing agent and a process for making the same are disclosed. The gloss reducing agent is the reaction product of (i) a compound having two or more epoxy groups per molecule and (ii) a compound having two or more amine groups per molecule, with the proviso that the total of epoxy groups of (i) and amine groups of (ii) per molecule is greater than 4. The gloss reducing agent may be either incorporated in ASA as the reaction product of (i) and (ii) or, in the alternative, formed upon the reaction of (i) with (ii) in the course of the thermal processing of the a blend containing ASA, (i) and (ii).
Patent AU-2002342883-A1 (AU)
Title: Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
Inventor: MAIZERAY PHILIPPE
IPC: A61K31/192
Filed: 2002-11-06
Abstract: The present invention relates to the use of a 4-oxobutanoic acid derivative for the preparation of a pharmaceutical composition for treating inflammation.
Patent AU-2002352016-A1 (AU)
Title: Crosslinked polyamine coating on superabsorbent hydrogels
Inventor: ROBINSON JIM
IPC: C08J3/12
Filed: 2002-11-15
Abstract: The invention concerns superabsorbent particles with a shell, wherein said shell comprises a cationic polymer crosslinked by the addition of crosslinker and adhered to hydrogel-forming polymer obtainable by applying a coating solution, containing both a cationic polymer and crosslinker, to hydrogel-forming polymer having a residual water content of less than 10 w%, their production and use.
Patent AU-2003202390-A1 (AU)
Title: E2 displacement assay for identifying inhibitors of hpv
Inventor: WHITE PETER
IPC: G01N33/535
Filed: 2003-02-04
Abstract: The present invention generally relates to an assay for identifying inhibitors of Human Papillomavirus (HPV), comprising:a) contacting a HPV E2 transactivation domain with a probe to form a E2:probe complex and measuring a signal from said probe to establish a base line level;b) incubating the E2:probe complex with a test compound and measuring the signal from said probe;c) comparing the signal from step b) with the signal from step a);wherein said probe is a compound of formula (I) or its enantiomers or diastereoisomers thereof:wherein R<1>, A, X, W, Y, R<3 >and R<4 >are as defined herein; or a derivative thereof, wherein said derivative is a probe of formula (I) labeled with a detectable label or an affinity tag, wherein wavy lines represent bonds of unspecified stereochemistry; and wherein said signal is selected from: fluorescence, resonance energy transfer, time resolved fluorescence, radioactivity, fluorescence polarization, change in the intrinsic spectral properties, luminescence and plasma-resonance; whereby a modulation in said signal is an indication that said test compound binds to said transactivation domain.
Patent AU-2003206792-A1 (AU)
Title: Method for overexpressing dehydrogenases
Inventor: SPELLIG TILMAN
IPC: C12N15/53
Filed: 2003-01-28
Abstract: Es wird ein Verfahren zur Überexpression von Dehydrogenasen, besonders zur Überexpression von DELTA1-Dehydrogenasen, insbesondere zur Überexpression von 3-Ketosteroid-DELTA1-Dehydrogenasen, sowie die für die Überexpression verwendbaren Bakterien, Plasmide und DNA-Sequenzen beschrieben.
Patent AU-2003209789-A1 (AU)
Title: Redundancy in process control system
Inventor: LAHTINEN ESA
IPC: G05B9/03
Filed: 2003-03-07
Abstract: The invention relates to a method and an apparatus for arranging redundancy in a process control system comprising at least one client device, at least one data source and at least one server device providing data transfer between the client device and the data source. The method comprises arranging, for the client device, at least two parallel logical connections for transferring substantially the same data between at least one data source and the client device. At the client device, property information on data units transferred via different logical connections is checked, the client device being provided with predetermined order criteria for the property information. At the client device, property information on parallel data units transferred via different logical connections is compared. Data units delivered via the logical connection having, according to the predetermined order criteria, the best property information are selected for the use of one or more applications processing the data units.
Patent AU-2003210908-A1 (AU)
Title: Wedgelock system
Inventor: DANELLO PAUL A
IPC: H05K7/14
Filed: 2003-02-06
Abstract: A symmetric wedgelock system includes a compression device having a longitudinal axis; a plurality of segments arranged along the compression device including at least one drive segment at each end and at least one working segment in between each working segment including at least two sections having diverging sides forming a concave wedge facing an associated drive segment; each drive segment having converging sides forming a convex wedge facing an associated working segment; the compression device includes an adjustment device for applying a compressive force along the longitudinal axis to drive the convex wedges of the drive segment into the concave wedges of the working segment to drive apart laterally the sections of the working segment.
Patent AU-2003231661-A1 (AU)
Title: Pharmaceutical preparation with RNA as hemostasis cofactor
Inventor: ROEMISCH JUERGEN
IPC: C12Q1/68
Filed: 2003-08-06
Abstract: A composition for promoting coagulation of blood comprising a natural or synthetic RNA, or its fragments or analogs, e.g. peptide nucleic acids, ribozymes or RNA aptamers (collectively (A)), is new. Independent claims are also included for: (1) composition for promoting fibrinolysis or for inhibiting coagulation containing one or more agents (B) that degrade RNA or inhibitory compounds with RNase activity or RNA-complexing capacity; (2) diagnostic process for detecting post-operative hypercoagulative states, complication of pregnancy, tumor status, acute myocardial infarction or sepsis by detecting increased levels of plasma RNA, relative to healthy subjects; and (3) diagnostic agent, containing (A), for qualitative or quantitative determination of the blood coagulation factor VII-activating protein (FSAP) or its proenzyme. ACTIVITY : Antibacterial; Immunosuppressive; Hemostatic; Anticoagulant; Thrombolytic; Cerebroprotective. No biological data given. MECHANISM OF ACTION : Modulating the effects of RNA, released from injured tissue or cells, which is an important initial cofactor in the induction of both extrinsic and intrinsic coagulation pathways; specifically RNA binds to and activates the factor VII-activating protease (FASP). RNA from different sources was added to a turbidimetric coagulation test and the recalcification time (RT) measured. All types of RNA tested significantly reduced RT (no figures given), but pretreatment of RNA with RNase destroyed this effect.
Patent AU-2003253042-A1 (AU)
Title: Method for determining unbalance of a clothes drum
Inventor: ZEH STEFAN
IPC: D06F34/16
Filed: 2003-07-09
Abstract: The imbalance detection method provides a characteristic value for the imbalance of a washing machine drum (13), which rotates about a horizontal axis, by measuring the periodic variations in the electrical power requirement of the drive motor (14), measured between a DC intermediate stage (26) and a controlled inverter (18) supplying the motor via a power measuring circuit (30).
Patent AU-2003258833-A1 (AU)
Title: Gas burner-type combustion device and method for operating same
Inventor: JAULENT GERARD
IPC: A01M21/04
Filed: 2003-06-27
Abstract: The present invention concerns a gas burner type combustion device called "burner" (B) projecting a mix of air and gas inflamed at the outlet of a pipe. The gas burner is fitted with a movable diffusion cone (200) whose tip (210) is located at least upstream from the flame creation zone so as to ensure the bursting of the air and gas mix, the relative displacement of the cone (200) according to the axis of diffusion defined by the flames allowing to adjust the strength of the latter.
Patent AU-2003259215-A1 (AU)
Title: Apparatus and method for optimizing cardiac pumping performance
Inventor: DING JIANG
IPC: A61N1/365
Filed: 2003-07-24
Abstract: A cardiac rhythm and function management device configured to automatically adjust stimulation parameters used in delivering cardiac resynchronization therapy. Mechanical contraction intervals are measured using appropriately placed accelerometers and compared with optimum values. The stimulation parameters can then be adjusted accordingly in a manner that moves the mechanical contraction intervals toward their optimum values.
Patent AU-2003275752-A1 (AU)
Title: A projector lifting device for a ceiling
Inventor: HAMMARGREN LARS
IPC: F16M11/04
Filed: 2003-10-29
Abstract: A projector lifting device for a ceiling structure comprises a projector lift suspended from a load-bearing construction (2) and which can displace a support element (21) carrying a projector (30) down through a rectangular opening in a ceiling structure (1) with ceiling panel (4') that is pre-stressed upwardly towards the ceiling structure by springs (60) so that its edge parts rest against the edges of the opening. The ceiling panel is opening by being displaced by the support element of the projector lifting device against the action of the springs (60) which automatically close the ceiling panel when the lifting device lifts the support element through the opening to above the level of the ceiling (1).
Patent WO-2004091293-A1 (WO)
Title: Hand operated agricultural chemical applicator
Inventor: POOLE NORMAN
IPC: A01C23/04
Filed: 2004-02-19
Abstract: A hand operated applicator (5) for the application of an agricultural liquid chemical preparation having a lance (10), an applicator head (25A/B, 30A/B), a series of small openings at spaced intervals along the underside of the applicator head (25A/B, 30A/B), a connector (65) for connecting the applicator (5) to a source of the agricultural liquid chemical preparation via a supply line and at least one means (60) to control flow of the agricultural liquid chemical preparation, wherein the applicator (5) has a generally T-shaped configuration formed by the lance (10) and the applicator head (25A/B, 30A/B). An agricultural liquid chemical preparation is pumped to an applicator (5) via a supply line at low pressure, the agricultural liquid chemical preparation is applied as droplets via a series of small openings in the underside of the head (25A/B, 30A/B) of the applicator (5) and the flow of the agricultural liquid chemical preparation is able to be adjusted by at least one flow control means (60) to deliver the agricultural liquid chemical preparation at a desired application rate.
Patent AU-2004231076-A1 (AU)
Title: Preparation of homogeneously loaded ion exchangers
Inventor: BOLLINGER MARK A
IPC: B01J47/00
Filed: 2004-04-12
Abstract: A process for preparing an ion-exchangeable media within a moving-bed or simulated moving-bed device, which can create a true or simulated media flow, comprising the steps of packing the bed with ion-exchangeable media and passing a solution, containing a mixture of ionic species, through the media, wherein the solution is passed partly or completely counter-current to the media flow direction such that the ionic species are loaded to a desired level upon equilibration.
Patent AU-2004238869-A1 (AU)
Title: Novel poly(ethylene glycol) modified compounds and uses thereof
Inventor: HOLMES CHRISTOPHER P
IPC: C07K1/107
Filed: 2004-05-12
Abstract: The present invention relates to a peptide-based compound comprising a peptide moiety and a poly(ethylene glycol) (PEG) moiety wherein the PEG moiety, which is preferably linear, has a molecular weight of more than 20 Kdaltons. The peptide moiety may be monomeric, dimeric or oligomeric. Such peptide-based compounds may optionally include a linker moiety and/or a spacer moiety, and are useful in drug delivery.
Patent AU-2004251726-A1 (AU)
Title: Carrier proteins for vaccines
Inventor: MICHON FRANCIS J
IPC: A61K39/385
Filed: 2004-06-23
Abstract: The present invention provides, among other things, improved carrier proteins for antigen-based vaccines, including polysaccharide-based vaccines. An aspect of the invention advantageously employs tetanus toxin Fragment C.
Patent AU-2004259444-A1 (AU)
Title: Security element for radio frequency identification
Inventor: PETERS JOHN ANTHONY
IPC: G06K19/067
Filed: 2004-07-16
Abstract: A security element for RF identification and a process for the production of such a security element. The security element has a flexible, electrically non-conducting substrate layer and a conductive layer of an electrically conducting material which is applied to the substrate layer and which in a first surface region of the substrate layer is shaped out in pattern form to form an RF component. A first relief structure is shaped at least in region-wise manner in the surface region, associated with the RF component, in the first conductive layer.
Patent AU-2004282355-A1 (AU)
Title: Additive for reducing paper linting and dusting
Inventor: MORNEAU DANIEL
IPC: D21H23/04
Filed: 2004-09-29
Abstract: The present invention relates to a new paper making composition useful for reducing linting and dusting in paper, a method for reducing paper linting and dusting wherein certain phosphate esters are added to a fiber pulp during the paper making process and the novel additive composition for reducing linting and dusting in paper comprising the phosphate ester.
Patent AU-2004302186-A1 (AU)
Title: Combining acknowledgement and rate control
Inventor: OSES DAVID PUIG
IPC: H04L1/00
Filed: 2004-08-04
Abstract: Embodiments disclosed herein address the need in the art for reduced overhead control with the ability to adjust transmission rates as necessary. In one aspect, a first signal indicates an acknowledgement of a decoded subpacket and whether or not a rate control command is generated, and a second signal conditionally indicates the rate control command when one is generated. In another aspect, a grant may be generated concurrently with the acknowledgement. In yet another aspect, a mobile station monitors the first signal, conditionally monitors the second signal as indicated by the first signal, and may monitor a third signal comprising a grant. In yet another aspect, one or more base stations transmit one or more of the various signals. Various other aspects are also presented. These aspects have the benefit of providing the flexibility of grant-based control while utilizing lower overhead when rate control commands are used, thus increasing system utilization, increasing capacity and throughput.
Patent WO-2005101274-A1 (WO)
Title: Systeme d'amarrage
Inventor: DYHRBERG ROGER WAYNE RICHARD
IPC: G06F19/00
Filed: 2005-04-19
Abstract: L'invention concerne un système (10) d'amarrage comprenant une base de données (24) conçue pour pouvoir mémoriser une pluralité d'enregistrements de donnée d'amarrage, chaque enregistrement contenant des informations concernant une place d'amarrage, des informations de réservation indiquant la réservation ou la disponibilité d'une place d'amarrage, et des données de réservation indiquant l'identité de l'utilisateur au nom duquel la place d'amarrage est réservé, et la date et/ou la période de réservation de la place d'amarrage. Le système (10) comprend également des moyens (22) de communication conçus pour faciliter les communications entre le système (10) et un dispositif utilisateur (12, 14, 16, 187, 19) éloigné, de manière à permettre la réception par le dispositif utilisateur éloigné des informations de réservation transmises par le système (10) d'amarrage, et la visualisation de ces informations par un utilisateur. L'invention concerne également un procédé connexe.
Patent WO-2005123301-A1 (WO)
Title: Refractaires de zircone pour la fabrication d'acier
Inventor: CARSON GRAHAM
IPC: C04B35/48
Filed: 2005-06-16
Abstract: La présente invention a trait à un matériau réfractaire pour la fabrication d'acier comportant entre 50 et 95 % de zircone (ZrO2), 0 et 35 % de silice (SiO2), 5 et 35 % de carbone (C), moins de 5 % d'alumine (Al2O3) et un antioxydant tel que du silicium métal (Si) et un carbure. L'antioxydant peut être présent en des quantités allant jusqu'à 10 % en poids. Le matériau réfractaire est utilisé dans la fabrication de buses de distribution et de pièces de transition. L'invention a également trait à un procédé de coulée en continu de bande d'acier comprenant les étapes suivantes: la mise en place d'une paires de rouleaux de laminage comportant une ligne de contact entre eux; la mise en place d'un système de distribution pour la distribution d'acier en fusion pour la formation d'un bassin de coulée comportant au moins du matériau réfractaire pour un contact avec l'acier en fusion comportant entre 50 et 95 % de zircone, 0 et 35 % de silice, 5 et 35 % de carbone, moins de 5 % d'alumine et un antioxydant et des carbures, et l'entraînement en rotation des rouleaux de laminage pour former une bande d'acier mince distribuée en direction de la ligne de contact.
Patent AU-2005203110-A1 (AU)
Title: Method and apparatus for performing non-scheduled transmission in a mobile communication system for supporting an enhanced uplink dedicated channel
Inventor: KWAK YONG-JUNE
IPC: H04B1/707
Filed: 2005-07-18
Abstract: A mobile communication system using an enhanced uplink dedicated transport channel transmits data at a relatively low effective data rate through autonomous transmission. Data transmission time points for user equipments (UEs) have different values in the autonomous transmission and therefore uplink interference is reduced. An autonomous transmission period N and the number of autonomous transmissions k are determined such that each UE performs the autonomous transmission. A Node B and each UE are notified of possible autonomous transmission time points based on the determined autonomous transmission period N and the determined number of autonomous transmissions k through signaling. The UE transmits the uplink data without the Node B's scheduling at the possible autonomous transmission time points.
Patent AU-2005215881-A1 (AU)
Title: Ionic UV-A sunscreens and compositions containing them
Inventor: SPRENGER DANIEL
IPC: C07F9/59
Filed: 2005-02-11
Abstract: The present invention relates to novel 1,4-dihydropyridine derivatives, to novel cosmetic or dermatological sunscreen compositions containing these derivatives and the use of these derivatives for photoprotecting human skin and/or hair against UV radiation, in particular solar radiation.
Patent AU-2005240864-A1 (AU)
Title: A translucent roof panel
Inventor: CAROLAN JAMES
IPC: E04C2/54
Filed: 2005-05-06
Abstract: A translucent panel comprises a single body translucent material comprising an outer weather skin <B>2</B>, an inner liner skin <B>3</B> and a multi-wall support <B>4</B> extending between the outer and inner skins, both skins <B>2</B>, <B>3</B> and the support <B>4</B> being of translucent material. The panel comprises an overlap portion <B>10</B> at at least one end or side, the overlap portion <B>10</B> being of similar thickness to the outer weather skin <B>2</B>. The overlap portion <B>10</B> may be formed by the outer weather skin <B>10</B> with the multiwall support <B>4</B> with or without the liner skin <B>3</B> collapsed against its inner surface. The multiwall support <B>4</B> and the liner skin <B>3</B>, if present, may be forced against the outer weather skin <B>2</B> at the overlap portion <B>10</B>. This forcing may be by pressing or by heat pressing. A spacer <B>20</B> may be provided for extending between the inner liner skin <B>3</B> and a building frame element such as a purlin. The spacer <B>20</B> may be bonded to the panel adjacent the overlap portion <B>10</B>. The invention also extends to a panel with a spacer as described but without an overlap portion <B>10</B>.
Patent AU-2005247440-A1 (AU)
Title: Use of morphogenic proteins for treating cartilage defects
Inventor: RUEGER DAVID C
IPC: A61K38/18
Filed: 2005-05-24
Abstract: The present invention provides methods of repairing and regenerating cartilage tissue by administering into the cartilage or the area surrounding the cartilage a composition comprising a therapeutically effective amount of a morphogenic protein.
Patent AU-2005273752-A1 (AU)
Title: Method and device for treating fibrous wastes for recycling
Inventor: MAUGENDRE STEPHANE
IPC: C03B3/02
Filed: 2005-07-27
Abstract: The invention relates to a method for treating wastes, in particular from the production of mineral fibres such as fibreglass wool or rock fibres associated with organic binders and optionally with water or other metal and/or organic matters consisting in fusing a waste mass ( 9 ) by supplying a pure oxygen or an oxygen-enriched air in order to obtain a mineral material usable in the form of a vitreous raw material for glass melting and in inputting energy by means of at least one burner submerged under the waste mass ( 9 ). A device for carrying out said method is also disclosed.
Patent WO-2006079171-A1 (WO)
Title: Systeme d’aromatherapie
Inventor: DOWD KIERON
IPC: A47G9/00
Filed: 2006-01-30
Abstract: L’invention concerne un système d’aromathérapie comprenant un module distributeur (10) contenant une substance thérapeutique volatile. Ledit module distributeur est adapté pour être fixé de manière adhésive (22) sur une surface, et il comprend un substrat (16) et une couverture perméable (20) entre lesquels est retenue ladite substance. L’invention concerne également un procédé de distribution d’une substance aromathérapeutique à un utilisateur, ledit procédé incluant les étapes consistant à a. fournir ladite substance dans un module distributeur (10) ; b. fixer ledit module sur l’oreiller (12) de l'utilisateur.
Patent WO-2006110950-A1 (WO)
Title: Modèle in vivo pour le développement préclinique de médicaments
Inventor: THOMAS DAVID
IPC: C12N5/06
Filed: 2006-04-18
Abstract: L'invention concerne une tumeur modèle in vivo destinée à être utilisée dans la détermination de la réponse d'une tumeur à un médicament. Ainsi, l'invention concerne un modèle de tumeur qui est dérivé d'une cellule qui est capable de produire une tumeur imageable lorsqu'elle est introduite dans un animal non humain. L'invention concerne un procédé in vivo servant à évaluer les effets d'un composé testé sur la tumeur modèle. Les cellules préférées utilisées pour le modèle de tumeur comprennent les cellules de TSGI (tumeur stromale gastro-intestinale), des cellules abritant des mutations dans les protéines c-KIT et/ou les récepteurs PDGFRA et en particulier les cellules FDC-PI. Le modèle préféré est une souris.
Patent WO-2006113976-A1 (WO)
Title: Cric de levage
Inventor: MANGHAM STUART
IPC: B66F5/04
Filed: 2006-04-28
Abstract: L'invention concerne un cric de levage (10) qui comporte une portion de soulèvement (11) portée sur un châssis mobile (13). La portion de soulèvement (11) incorpore un vérin de soulèvement (15) et possède un axe de soulèvement (61) correspondant au sens dans lequel le vérin de soulèvement (15) peut s'étendre. La portion de soulèvement (11) a aussi une base (19) adaptée pour être en prise avec le sol (23), avec l'axe de soulèvement (61) s'étendant sensiblement verticalement. Le châssis mobile (13) supporte la portion de soulèvement (11) pour un déplacement sur le sol (23) et incorpore deux roues au sol (33) qui peuvent tourner autour d'un axe sensiblement horizontal. La portion de soulèvement (11) a un premier mode d'exploitation selon lequel la base (19) est en prise avec le sol (23) et l'axe de soulèvement (61) est sensiblement vertical. La portion de soulèvement (11) a aussi un deuxième mode d'exploitation selon lequel la base (19) est élevée au-dessus du sol (23) et l'axe de soulèvement (61) est sensiblement vertical. La portion de soulèvement (11) a aussi un troisième mode d'exploitation selon lequel la portion de soulèvement (11) a été pivotée vers le haut autour de l'axe horizontal dans un état incliné facilitant le déplacement des roues du cric de levage sur le sol.